000 01376 a2200361 4500
005 20250513032754.0
264 0 _c19951102
008 199511s 0 0 eng d
022 _a0002-9343
024 7 _a10.1016/s0002-9343(99)80187-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAuger, W R
245 0 0 _aLupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report.
_h[electronic resource]
260 _bThe American journal of medicine
_cOct 1995
300 _a392-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnticoagulants
_xadverse effects
650 0 4 _aCase-Control Studies
650 0 4 _aChronic Disease
650 0 4 _aHeparin
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xblood
650 0 4 _aLupus Coagulation Inhibitor
_xblood
650 0 4 _aMedical Records
650 0 4 _aPlatelet Count
_xdrug effects
650 0 4 _aRetrospective Studies
650 0 4 _aThrombocytopenia
_xchemically induced
650 0 4 _aThromboembolism
_xblood
700 1 _aPermpikul, P
700 1 _aMoser, K M
773 0 _tThe American journal of medicine
_gvol. 99
_gno. 4
_gp. 392-6
856 4 0 _uhttps://doi.org/10.1016/s0002-9343(99)80187-9
_zAvailable from publisher's website
999 _c7572550
_d7572550